[go: nahoru, domu]

Latest News for: eli lilly

Edit

Americans hungry for weight-loss drugs grapple with supply and insurance hurdles

West Hawaii Today 05 Nov 2024
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed on Dec ... Americans are still eagerly seeking prescriptions for Eli Lilly and Novo Nordisk’s weight-loss and diabetes drugs ...
Edit

NJ drugmaker paying $10M to settle claims it conspired with others to jack up prices

app 05 Nov 2024
Pharmaceutical companies slash insulin prices, following Biden's suit. President Joe Biden praised the companies, Eli Lilly and Novo Nordisk, for slashing prices of insulin, making it more affordable for patients. Anastasiia Riddle, USA TODAY.
Edit

Microdosing Ozempic? Why some people are playing doctor with weight-loss drugs

The Los Angeles Times 05 Nov 2024
Dr ... Dr ... Last week, the Food and Drug Administration announced that the shortage of Eli Lilly's Zepbound was over, though Wegovy remains scarce. Eli Lilly then sent cease-and-desist letters to many companies offering compounded versions of tirzepatide.
Edit

New obesity pill is safe and tolerable in early stage trial: AstraZeneca

Khaleejtimes 04 Nov 2024
... from Eccogene a year ago for up to $2 billion, it said it believed the treatment could cause fewer side effects than current injectable treatments such Eli Lilly's Zepbound and Novo Nordisk's Wegovy.
Edit

Big Pharma's Obesity Bonanza Faces New Tests

Wall Street Journal 04 Nov 2024
The next few months will be crucial for obesity players Eli Lilly, Novo Nordisk and Amgen. .
Edit

Analysis-Americans Hungry for Weight-Loss Drugs Grapple With Supply and Insurance Hurdles

US News 04 Nov 2024
By Patrick Wingrove and Bhanvi Satija(Reuters) - Americans are still eagerly seeking prescriptions for Eli Lilly and Novo Nordisk's weight-loss and... .
Edit

Should you buy Viking Therapeutics (VKTX) after today’s spike?

Invezz 04 Nov 2024
This oral formulation targets the dual GLP-1/GIP receptors and positions Viking as a competitive player alongside giants like Eli Lilly and Novo Nordisk in the lucrative obesity treatment market.
Edit

Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs

Time Magazine 04 Nov 2024
Novo Nordisk, the drug company that makes Ozempic and Wegovy, and Eli Lilly, the manufacturer of Mounjaro and Zepbound, do not deny that their drugs cause side effects, most often involving GI discomfort.
Edit

Americans seeking Eli Lilly and Novo Nordisk’s weight-loss drugs turn to compounded market

Fast Company 04 Nov 2024
Americans are still eagerly seeking prescriptions for Eli Lilly and Novo Nordisk’s weight-loss and diabetes drugs but cannot always fill them because of supply issues and insurance hurdles, according to their doctors.
Edit

UVU roundup: Wolverine women’s cross country wins WAC title

Provo Daily Herald 04 Nov 2024
... before beating teammate Yusief Lillie in the semifinals in a bout that went to sudden victory ... Lillie and Eli Stafford both were scheduled for fifth-place matches, but those matches were not completed.
Edit

Outrage as ultra-wealthy tech tycoon

The Daily Mail 04 Nov 2024
Boston-based biotech maven Praveen Tipirneni has a track record in sealing multibillion dollar deals ... a puppy store in New Hampshire ... He's now the CEO of Morphic Therapeutic, a drug research firm that was bought by Eli Lilly for $3.2 billion in June ... .
Edit

KFSHRC & Lilly Collaborate In Alzheimer's Early Detection

MENA FN 03 Nov 2024
(MENAFN - EIN Presswire). RIYADH, Saudi Arabia, Nov. 03, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) and Eli Lilly Saudi Arabia signed an MoU today to ... .
Edit

KFSHRC & Lilly Collaborate In Alzheimer’S Early Detection

MENA FN 03 Nov 2024
(MENAFN - GlobeNewsWire - Nasdaq) RIYADH, Saudi Arabia, Nov. 03, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) and Eli Lilly Saudi Arabia signed an MoU today ... .
Edit

Eli Lilly Has a Major Problem With Its Weight Loss Drugs Zepbound and Mounjaro

Futurism 02 Nov 2024
Eli Lilly, the maker of the popular weight loss drug Zepbound, revealed what Bloomberg called a "shocking first miss" in its most recent quarterly sales announcement ... Eli Lilly pointed the finger at ...

Most Viewed

×